Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value: $113M (100.0% shares, 0.0% debt)

Holdings (12)

— Abeona Therapeutics Inc 33.0%

Value $37.4M Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Corbus Pharmaceuticals HLDGS 24.1%

Value $27.39M Shares 3,856,985 Est. Cost $4.41 Unrealized —

— Biohaven Pharmactl Hldg Co L 19.2%

Value $21.78M Shares 807,224 Est. Cost $25.00 Unrealized —

— Ampio Pharmaceuticals Inc. 9.3%

Value $10.56M Shares 2,595,484 Est. Cost $6.03 Unrealized —

— Vascular Biogenics LTD 5.6%

Value $6.367M Shares 896,771 Est. Cost $4.71 Unrealized —

KRYS Krystal Biotech Inc 2.8%

Value $3.156M Shares 300,000 Est. Cost $10.08 Unrealized -0.6%

AVXL Anavex Life Sciences Corp 2.1%

Value $2.332M Shares 724,205 Est. Cost $3.56 Unrealized +10.5%

— Soligenix Inc. 1.6%

Value $1.835M Shares 870,000 Est. Cost $2.11 Unrealized —

VNRX Volition RX LTD 0.9%

Value $1.034M Shares 351,538 Est. Cost $3.75 Unrealized -22.1%

ALDX Aldeyra Therapeutics Inc 0.7%

Value $844K Shares 124,096 Est. Cost $10.20 Unrealized -35.4%

— Evoke Pharma Inc 0.5%

Value $622K Shares 275,000 Est. Cost $2.99 Unrealized —

— Advaxis Inc. 0.1%

Value $113K Shares 112,500 Est. Cost $3.96 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Abeona Therapeutics Inc	2,359,767	$37.4M	33.0%	$4.97	—	COM	00289Y107
—	Corbus Pharmaceuticals HLDGS	3,856,985	$27.39M	24.1%	$4.41	—	COM	21833P103
—	Biohaven Pharmactl Hldg Co L	807,224	$21.78M	19.2%	$25.00	—	COM	G11196105
—	Ampio Pharmaceuticals Inc.	2,595,484	$10.56M	9.3%	$6.03	—	COM	03209T109
—	Vascular Biogenics LTD	896,771	$6.367M	5.6%	$4.71	—	COM	M96883109
KRYS	Krystal Biotech Inc	300,000	$3.156M	2.8%	$10.08	-0.6%	COM	501147102
AVXL	Anavex Life Sciences Corp	724,205	$2.332M	2.1%	$3.56	+10.5%	COM NEW	032797300
—	Soligenix Inc.	870,000	$1.835M	1.6%	$2.11	—	COM	834223307
VNRX	Volition RX LTD	351,538	$1.034M	0.9%	$3.75	-22.1%	COM	928661107
ALDX	Aldeyra Therapeutics Inc	124,096	$844K	0.7%	$10.20	-35.4%	COM	01438T106
—	Evoke Pharma Inc	275,000	$622K	0.5%	$2.99	—	COM	30049G104
—	Advaxis Inc.	112,500	$113K	0.1%	$3.96	—	W EXP 07/15/201	007624117